The 20 Best Paget Disease of the Breast Doctors Near Me in Brighton, MA

Dr. Mayer received her medical degree from Harvard Medical School, completed her residency in Internal Medicine at Brigham and Women's Hospital, and her fellowship in Medical Oncology at the Dana-Farber Cancer Institute. She also obtained a Masters in Public Health from the Harvard School of Public Health. She joined the staff of Dana-Farber and Brigham and Women's Hospital in 2006, where she serves as Director of Breast Cancer Clinical Research. She is a breast cancer medical oncologist and clinical investigator leading research studies focused on novel therapies for the treatment of breast cancer. Dr. Mayer is rated as a Distinguished provider by MediFind in the treatment of Paget Disease of the Breast. Her top areas of expertise are Breast Cancer, Inflammatory Breast Cancer, Paget Disease of the Breast, and Angiosarcoma.

Dr. Tolaney is Chief of the Division of Breast Oncology at Dana-Farber Cancer Institute, and Associate Professor of Medicine at Harvard Medical School.  She is a breast medical oncologist whose research focuses on the development of novel therapies in the treatment of breast cancer.  She has been instrumental in developing several treatment approaches for breast cancer, including approaches focused on tailoring therapy for early stage HER2+ disease, use of cdk 4/6 inhibitors, antibody drug conjugates, and immunotherapy.She is a member of the National Cancer Institute Breast Cancer Steering Committee and is Vice Chair for Late-Stage Development in Breast Cancer in the Alliance for Clinical Trials in Oncology. Her research has been funded by the Breast Cancer Research Foundation and Susan G. Komen. She currently chairs multiple phase 3 trials in breast cancer and serves on several steering committees for practice-changing trials.  Her work has been published in journals such as the New England Journal of Medicine, Lancet, Lancet Oncology, Journal of Clinical Oncology, and others. She received her undergraduate degree from Princeton University in 1998 and her medical degree from UC San Francisco in 2002. She subsequently completed her residency in Internal Medicine at Johns Hopkins University, and fellowships in hematology and medical oncology at Dana-Farber Cancer Institute. She obtained a Masters in Public Health from the Harvard School of Public Health in 2007. In 2008, she joined the staff of Dana-Farber Cancer Institute and Brigham and Women's Hospital. Dr. Tolaney is rated as a Distinguished provider by MediFind in the treatment of Paget Disease of the Breast. Her top areas of expertise are Breast Cancer, HER-2 Positive Breast Cancer, Inflammatory Breast Cancer, and Triple-Negative Breast Cancer.

Susan Schumer is an Oncologist in Boston, Massachusetts. Dr. Schumer is rated as a Distinguished provider by MediFind in the treatment of Paget Disease of the Breast. Her top areas of expertise are Inflammatory Breast Cancer, Breast Cancer, Angiosarcoma, and Paget Disease of the Breast.

Dr. Jennifer Ligibel is a Professor at Harvard Medical School, the Director of the Leonard P. Zakim Center for Integrative Therapies and Healthy Living, and the Director of the Center for Faculty Well-Being at the Dana-Farber Cancer Institute. Dr. Ligibel’s research focuses on the impact of lifestyle interventions upon cancer-related outcomes in women with breast cancer. She has conducted a number of studies looking at the impact of exercise and weight loss interventions upon patients’ quality of life and symptoms after cancer diagnosis and is currently leading an NCI-funded Phase III clinical trial that will test the impact of a weight loss intervention upon the risk of disease recurrence in more than 3000 overweight and obese women with early-stage breast cancer. Dr. Ligibel was the Chair of the American Society of Clinical Oncology Subcommittee on Energy Balance, which has developed patient and physician materials to help facilitate healthy lifestyle changes after cancer diagnosis. Dr. Ligibel is rated as a Distinguished provider by MediFind in the treatment of Paget Disease of the Breast. Her top areas of expertise are Breast Cancer, Inflammatory Breast Cancer, Paget Disease of the Breast, Angiosarcoma, and Hormone Replacement Therapy (HRT).

Dr. Lin is a medical oncologist specializing in the care of patients with all stages of breast cancer. Her research focuses upon improving the outcomes of people living with metastatic breast cancer, including a particular focus on the challenge of breast cancer brain metastases. She has led multiple clinical trials which have led to new treatment options for patients with breast cancer that has metastasized to the brain. Dr. Lin received her MD from Harvard Medical School in 1999. She completed her residency in internal medicine at Brigham and Women's Hospital and went on to complete fellowships in medical oncology and hematology at Dana-Farber. In 2005, she joined the staff of Brigham and Women's and Dana-Farber, where she is a medical oncologist and clinical investigator in the Breast Oncology Center. Dr. Lin is rated as a Distinguished provider by MediFind in the treatment of Paget Disease of the Breast. Her top areas of expertise are Breast Cancer, HER-2 Positive Breast Cancer, Brain Tumor, and Inflammatory Breast Cancer.

Rochelle Scheib is an Oncologist in Boston, Massachusetts. Dr. Scheib is rated as a Distinguished provider by MediFind in the treatment of Paget Disease of the Breast. Her top areas of expertise are Breast Cancer, Inflammatory Breast Cancer, Paget Disease of the Breast, and Angiosarcoma.

Dr. Nakhlis received her medical degree from Rush Medical College in Chicago in 1996. She subsequently completed her residency in general surgery and her breast surgery fellowship at Northwestern University in Chicago. She is an attending physician in the Brigham and Women's Hospital and Brigham and Women’s Faulkner Hospital in Boston and an assistant professor of surgery at Harvard Medical School. Her clinical research interests are focused on lobular neoplasia and other premalignant and proliferative breast lesions, and inflammatory breast cancer. Dr. Nakhlis is rated as a Distinguished provider by MediFind in the treatment of Paget Disease of the Breast. Her top areas of expertise are Inflammatory Breast Cancer, Breast Cancer, Intraductal Papilloma, Mastectomy, and Lymphadenectomy.

Dr. Waks received her undergraduate degree from Princeton University in 2006 and her MD degree from Harvard Medical School in 2011. She completed residency training in internal medicine at Brigham and Women's Hospital, where she subsequently served an additional year as a Chief Resident in Internal Medicine. She completed fellowship training in medical oncology at Dana-Farber/Partners CancerCare, then joined the staff of the Breast Oncology Center at Dana-Farber Cancer Institute. Dr. Waks is rated as a Distinguished provider by MediFind in the treatment of Paget Disease of the Breast. Her top areas of expertise are Breast Cancer, HER-2 Positive Breast Cancer, Inflammatory Breast Cancer, and Angiosarcoma.

Dr. Partridge received her MD from Cornell University Medical College in 1995. She completed her residency in internal medicine at the Hospital of the University of Pennsylvania and went on to complete fellowships in medical oncology and hematology at DFCI, MGH and BWH. She also received an MPH from Harvard School of Public Health. She is a medical oncologist who cares for adults with breast cancer, with a particular focus on the unique needs of young patients with breast cancer. She also leads efforts to optimize cancer survivorship care and research at DFCI. She completed fellowships in Medical Oncology and Hematology at DFCI, Massachusetts General Hospital and Brigham and Women’s Hospital. Dr. Partridge is rated as a Distinguished provider by MediFind in the treatment of Paget Disease of the Breast. Her top areas of expertise are Breast Cancer, Inflammatory Breast Cancer, BRCA Positive Breast Cancer, Hormone Replacement Therapy (HRT), and Salpingo-Oophorectomy.

Steven Come is an Internal Medicine specialist and an Oncologist in Boston, Massachusetts. Dr. Come is rated as a Distinguished provider by MediFind in the treatment of Paget Disease of the Breast. His top areas of expertise are Breast Cancer, Angiosarcoma, Inflammatory Breast Cancer, and Paget Disease of the Breast.

Lowell Schnipper is an Internal Medicine specialist and an Oncologist in Boston, Massachusetts. Dr. Schnipper is rated as a Distinguished provider by MediFind in the treatment of Paget Disease of the Breast. His top areas of expertise are Inflammatory Breast Cancer, Breast Cancer, Paget Disease of the Breast, and Angiosarcoma.

Nadine Tung is an Internal Medicine specialist and an Oncologist in Boston, Massachusetts. Dr. Tung is rated as a Distinguished provider by MediFind in the treatment of Paget Disease of the Breast. Her top areas of expertise are Breast Cancer, Ovarian Cancer, BRCA Positive Breast Cancer, Salpingo-Oophorectomy, and Hormone Replacement Therapy (HRT).

Gerburg Wulf is an Internal Medicine provider in Boston, Massachusetts. Dr. Wulf is rated as a Distinguished provider by MediFind in the treatment of Paget Disease of the Breast. Her top areas of expertise are Breast Cancer, Paget Disease of the Breast, Inflammatory Breast Cancer, Triple-Negative Breast Cancer, and Hormone Replacement Therapy (HRT).

Panagiotis Fidias is an Internal Medicine provider in Boston, Massachusetts. Dr. Fidias is rated as a Distinguished provider by MediFind in the treatment of Paget Disease of the Breast. His top areas of expertise are Lung Cancer, Pleuropulmonary Blastoma, Familial Colorectal Cancer, and Colorectal Cancer.

Barbara Smith is a General Surgeon and a Surgical Oncologist in Boston, Massachusetts. Dr. Smith is rated as a Distinguished provider by MediFind in the treatment of Paget Disease of the Breast. Her top areas of expertise are Paget Disease of the Breast, Breast Cancer, Angiosarcoma, Inflammatory Breast Cancer, and Lymphadenectomy.

Dr. Esther Rhei a surgeon at Brigham and Women’s Hospital (BWH), Brigham and Women’s Faulkner Hospital and Dana-Farber Brigham Cancer Center, and an assistant professor of surgery at Harvard Medical School. Dr. Rhei received her medical degree from Rutgers Robert Wood Johnson Medical School. She then completed a general surgery residency at State University of New York Health Science Center at Brooklyn and a fellowship at Memorial Sloan Kettering Cancer Center. Dr. Rhei is board certified in surgery. Her clinical and research interests include benign breast disease, breast cancer, and decision making in breast cancer surgery. She has received numerous teaching awards from Harvard Medical School and the Department of Surgery. Dr. Rhei has been named to Marquis Who's Who in the World, America's Top Doctors by Castle Connolly, and Top Doctor in Boston Magazine since 2012. Dr. Rhei is rated as a Distinguished provider by MediFind in the treatment of Paget Disease of the Breast. Her top areas of expertise are Breast Cancer, Angiosarcoma, Inflammatory Breast Cancer, Lymphadenectomy, and Mastectomy.

Michelle Specht is a General Surgeon and a Surgical Oncologist in Boston, Massachusetts. Dr. Specht is rated as a Distinguished provider by MediFind in the treatment of Paget Disease of the Breast. Her top areas of expertise are Breast Cancer, Angiosarcoma, Inflammatory Breast Cancer, Mastectomy, and Lymphadenectomy.

Elizabeth Walsh is an Oncologist in Boston, Massachusetts. Dr. Walsh is rated as a Distinguished provider by MediFind in the treatment of Paget Disease of the Breast. Her top areas of expertise are Paget Disease of the Breast, Breast Cancer, Familial Colorectal Cancer, and Familial Pancreatic Cancer.

Dr. Metzger received his MD from Federal University of Minas Gerais in 2003 and completed training in Internal Medicine and Medical Oncology in 2008. Following his formal training, he spent three years at the Institute Jules Bordet in Brussels where he completed a research fellowship and initiated a career dedicated to understanding the biological features of the second most common histological subtype of breast cancer - invasive lobular carcinoma. Since joining the Breast Oncology Program at Dana-Farber Cancer Institute in 2012, he has established an active clinical practice and developed research efforts focused on identifying better treatment strategies for patients diagnosed with breast cancer. He is involved in designing and leading national and international clinical trials with a strong translational component. In addition to his physician and clinical investigator roles, Dr. Metzger holds an Executive Officer position at the Alliance for Clinical Trials in Oncology. Dr. Metzger is rated as an Advanced provider by MediFind in the treatment of Paget Disease of the Breast. His top areas of expertise are Breast Cancer, Paget Disease of the Breast, Inflammatory Breast Cancer, and HER-2 Positive Breast Cancer.

Dr. Varella is a clinical expert in the care of patients with breast cancer. She  was born in Sao Paulo, Brazil where she completed her training in Medical Oncology. She moved to the United States for a research fellowship in cancer Immunology at the Cleveland Clinic, followed by a clinical fellowship in Experimental Therapeutics. Following her residency in Internal Medicine, she spent a year as a Chief Resident at Memorial Sloan Kettering Cancer Center. She then completed a fellowship in Hematology & Oncology at the Cleveland Clinic.After her training, Dr. Varella joined the breast cancer group coming from Weill Cornell Medical College in New York where she was an Assistant Professor of Medicine specialized in the treatment of breast cancer. Dr. Varella has a special clinical and research focus on improving outcomes in young patients with breast cancer. Her recent research innovations include leading a project at DFCI in which she is investigating the factors associated with survival in young patients with metastatic breast cancer from the Young Women’s Breast Cancer study (YWS) at DFCI. She also supervises and teaches Internal Medicine residents and Medical Oncology fellows at DFCI. Dr. Varella is rated as an Advanced provider by MediFind in the treatment of Paget Disease of the Breast. Her top areas of expertise are Inflammatory Breast Cancer, Paget Disease of the Breast, Angiosarcoma, and Breast Cancer.